Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls.

Andrea L RossoZachary A MarcumXiaonan ZhuNicolaas BohnenCaterina Rosano

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2021)

Higher dopaminergic signaling may provide protection against increased 12-month fall risk from anticholinergic use. Assessing vulnerability to the adverse effects of anticholinergic medications could help in determination of risk/benefit ratio for prescribing and deprescribing anticholinergics in older adults.

Keyphrases

primary care
climate change
physical activity
adverse drug
emergency department
tandem mass spectrometry